![Roland Wandeler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roland Wandeler
Corporate Officer/Principal chez
GRIFOLS, S.A.
Profil
Roland Wandeler is President-Biopharma Business Unit at Grifols SA since 2024.
Former roles include Chief Executive Officer at Sundance Biosciences, Inc. from 2022 to 2023, VP, GM-US Bone Health & Cardiology Business Unit at Amgen, Inc., and Chief Operating Officer at MorphoSys AG from 2020 to 2021.
Education includes graduate and doctorate degrees from the Swiss Federal Institute of Technology.
Postes actifs de Roland Wandeler
| Sociétés | Poste | Début |
|---|---|---|
| GRIFOLS, S.A. | Corporate Officer/Principal | 01/01/2024 |
Anciens postes connus de Roland Wandeler
| Sociétés | Poste | Fin |
|---|---|---|
Encinal Bio, Inc. | Directeur Général | 01/10/2023 |
| MORPHOSYS AG | Directeur des opérations | 31/12/2021 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Roland Wandeler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Grifols SA
 Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Encinal Bio, Inc. |
